Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Bosen Biological Pharmaceutical Group Co., Ltd. is a comprehensive, high-tech pharmaceutical enterprise founded in 2002 and based in Xi'an, China. The company integrates scientific research, development, manufacturing, and sales of a wide range of pharmaceutical products, including freeze-dried powder injections, small-volume injections, tablets, capsules, granules, and eye drops. Shaanxi Bosen's commercial portfolio spans multiple therapeutic areas such as cardiovascular diseases, anti-infectives, metabolic disorders, and neurological conditions, featuring products like asparagine injection, gastrodin injection, and metformin hydrochloride. Additionally, the company is actively developing traditional Chinese medicine (TCM) formulations, with its Shun-Qi-Tong-Xie (SQTX) Granule in Phase III clinical trials for irritable bowel syndrome with diarrhea (IBS-D) and Shenmishu Capsule in Phase II for cystitis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Bosen Biological Pharmaceutical Group.